Similar articles

• [The BAFTA study].

  Di Pasquale G, Palareti G. Di Pasquale G, et al. G Ital Cardiol (Rome). 2008 Nov;9(11):735-9. G Ital Cardiol (Rome). 2008. PMID: 19058663 Italian. No abstract available.
• Is there less benefit from warfarin in diabetics after myocardial infarction? The numbing complexities of assessing anticoagulant and antiplatelet therapy in the diabetic patient.

  Smith DA. Smith DA. Cardiology. 2008;111(3):158-60. doi: 10.1159/000121597. Epub 2008 Apr 25. Cardiology. 2008. PMID: 18434718 No abstract available.
• ALS lessons learned from other neurological diseases. Neuro-oncology.

  Schold SC Jr. Schold SC Jr. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:34-5. doi: 10.1080/17434470410019771. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512867 Review. No abstract available.
• Randomized control trials in ALS: lessons learned.

  Mitsumoto H, Gordon P, Kaufmann P, Gooch CL, Przedborski S, Rowland LP. Mitsumoto H, et al. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004 Sep;5 Suppl 1:8-13. doi: 10.1080/17434470410019942. Amyotroph Lateral Scler Other Motor Neuron Disord. 2004. PMID: 15512861 Review. No abstract available.
• Risks and benefits of combining aspirin with anticoagulant therapy in patients with atrial fibrillation: an exploratory analysis of stroke prevention using an oral thrombin inhibitor in atrial fibrillation (SPORTIF) trials.

  Flaker GC, Gruber M, Connolly SJ, Goldman S, Chaparro S, Vahanian A, Halinen MO, Horrow J, Halperin JL; SPORTIF Investigators. Flaker GC, et al. Am Heart J. 2006 Nov;152(5):967-73. doi: 10.1016/j.ahj.2006.06.024. Am Heart J. 2006. PMID: 17070169